JB
James Behrmann
Credentials:
History
- 2024–2027
Residency
- 2020–2024
Medical School
Research
Cancers · 2024 · 6 citations
Frontiers in Oncology · 2022 · 6 citations
Dual target combination therapy demonstrates promise in extramedullary myeloma
Letter or commentary · Translational Cancer Research · 2026 · First of 2 authors · Corresponding

2 papers
- MA
2 papers

1 paper

1 paper

1 paper · 1 as a fellow
- DP
1 paper

1 paper

1 paper


